Women who work nightshifts are more likely to have asthma
Women who work night shifts are more likely to suffer with moderate or severe asthma compared to women who work in the daytime, according to a study published… read more.
Women who work night shifts are more likely to suffer with moderate or severe asthma compared to women who work in the daytime, according to a study published… read more.
The most comprehensive analysis of rheumatoid arthritis data to date reveals that demographic changes and uneven health infrastructure have exacerbated the rheumatoid arthritis burden since 1980 and shows… read more.
BeiGene, Ltd announced that the Committee for Medicinal Products for Human Use (CHMP) of the EMA issued a positive opinion recommending approval of Tevimbra (tislelizumab), in combination with gemcitabine… read more.
Canada can learn from England’s successful diabetes prevention program to build its own programs to tackle diabetes prevention across the country, argue authors in an analysis in CMAJ (Canadian Medical Association… read more.
Sobi will be presenting a wide range of clinical study updates at the annual International Society on Thrombosis and Haemostasis (ISTH) Congress in Washington (21-25 June). With ten (10)… read more.
The Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending a change to the marketing authorisation for Zoonotic Influenza Vaccine Seqirus. The marketing authorisation… read more.
A new study from Emory University addresses the growing global crisis of antibiotic-resistant infections. Many of these drug-resistant bacteria are spread through hospitals, and there are few antibiotics… read more.
Football’s governing body FIFA should drop Coca-Cola as sponsors of the 2025 Club World Cup which begins this week, urge doctors in The BMJ today. Dr Chris van Tulleken at… read more.
Amgen announced full results from Part 1 of the Phase II study for MariTide (maridebart cafraglutide, formerly AMG 133) in patients living with obesity, with and without Type… read more.
Roche announced the launch of its Elecsys PRO-C3 test, a new diagnostic solution designed to assess the severity of liver fibrosis in patients showing signs of metabolic dysfunction–associated… read more.
A new study from the University of Colorado Anschutz Medical Campus shows that primary care clinics can successfully help patients start using continuous glucose monitors (CGMs), which track blood sugar… read more.
Increased activity in a specific biological pathway may explain why many patients with a deadly form of skin cancer do not respond to the latest cancer treatments, a… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.